Decision analytic modeling and NSAID gastropathy - Could we be more sensitive?

被引:4
作者
Fendrick, AM [1 ]
Scheiman, JM
机构
[1] Univ Michigan, Consortium Hlth Outcomes Innovat & Cost Effective, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Div Gen Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA
关键词
D O I
10.1046/j.1525-1497.2000.0004009.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:430 / 431
页数:2
相关论文
共 5 条
[1]   Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer [J].
Fendrick, AM ;
Chernew, ME ;
Hirth, RA ;
Bloom, BS ;
Bandekar, RR ;
Scheiman, JM .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (02) :142-148
[2]   RISK FOR SERIOUS GASTROINTESTINAL COMPLICATIONS RELATED TO USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A METAANALYSIS [J].
GABRIEL, SE ;
JAAKKIMAINEN, L ;
BOMBARDIER, C .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :787-796
[3]   Cost-effectiveness of strategies for primary prevention of nonsteroidal anti-inflammatory drug-induced peptic ulcer disease [J].
Ko, CW ;
Deyo, RA .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (06) :400-410
[4]   Excess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugs [J].
Smalley, WE ;
Griffin, MR ;
Fought, RL ;
Ray, WA .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (08) :461-469
[5]   Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs [J].
Wolfe, MM ;
Lichtenstein, DR ;
Singh, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (24) :1888-1899